Status:
RECRUITING
Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis
Lead Sponsor:
National Institute of Cancerología
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Endometrial Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Endometrial cancer (EC) is one of the most common gynecological neoplasms, being the second in incidence and third in mortality in Mexico. Recent studies show that EC molecular classification (Cancer ...
Detailed Description
The investigators will carry out a pilot study on patients with endometrioid type EC treated between 2015-2019. Samples of patients over 18 years of age admitted to the cohort with a diagnosis of endo...
Eligibility Criteria
Inclusion
- Criteria:
- Clinical diagnosis of endometrioid-type endometrial cancer with samples available
- That the patients have undergone surgery at INCan.
Exclusion
- Samples with CEE of non-endometroid type.
- Samples from patients with double primary neoplasm, including carcinoma ductal in situ, squamous cell skin cancers, and cervical carcinoma in situ
- History of malignancy \< 5 years prior with no evidence of disease (i.e., remission).
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06206083
Start Date
March 1 2024
End Date
February 1 2027
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Cancerología
Mexico City, Mexico City, Mexico, 14080